Newsletter Current page: 9

numares AG, a leader in NMR metabolomics-based diagnostics, has developed a novel multi-marker approach – GFRNMR – to determine kidney function using simple serum tests. The combination of multiple renal biomarkers can exceed the diagnostic limitations of the established method for estimating GFR (glomerular filtration rate). The assessment of kidney function is extremely important for […]

“OPN-NC Super High Pressure PTCA-Balloon” is the name of the high-pressure balloon catheter from the Swiss company SIS Medical AG, which achieved comparable, often even higher stent expansion compared to conventional balloon catheters in a successfully completed study on 74 heart patients. At the same time, the treatment success can be achieved in only one […]

After leading the Balingen-based homecare specialist medigroba GmbH on an impressive growth course over the past five years, SHS is now selling the company to Löwenstein Group. The medigroba management is confident that it will be able to continue on its successful course within Löwenstein Group, because there are more and more people who are […]

In the first part of the series ESG Investing (Environment, Social, Governance), Dr. André Zimmermann, Partner and Head of ESG at SHS, wrote about the basic principles of socially responsible investing. Today, we will take a closer look at how SHS implements ESG and SRI (Socially Responsible Investing) in concrete terms. Since its foundation almost […]

Chronic back pain is one of the most common pains in industrial societies; and sometimes it is so unbearable that only surgery with a spinal implant can help. Blue Ocean Spine GmbH is developing new types of spinal implants that can be individually adapted in situ, some of which even manage without additional screw fixation. […]

In future, we will introduce the SHS senior advisors to you here. The experience of these experts plays an important role for us in the investment process and benefits not least our portfolio companies. After completing his engineering studies, Heinz Jacqui worked for many years in top management positions at globally successful medium-sized companies. Most […]

The German Pain Society estimates the number of chronic pain patients in Germany alone at around 23 million people. These include, for example, cancer patients who suffer from severe, chronic pain that can usually only be treated with opioid analgesics. For these patients, among others, the SHS portfolio company Develco Pharma develops and produces orally […]

The Single Use Support GmbH (SUS) product system for use in the deep-frozen transport of sensitive substances is well on its way to becoming the gold standard in liquid logistics. Companies all over the world, in the fields of life science, biotech and pharma, including firms engaged in research for coronavirus vaccines, rely on products […]

The Dutch medtech company Salvia BioElectronics B.V. specialises in the treatment of chronic migraine with electromedical solutions for neurostimulation. The news that Salvia has received the coveted Breakthrough Device Designation from the United States FDA gives creates a reason for hope among millions of migraine patients in the USA. This will significantly accelerate the approval […]

‘Milestones in medical technology’ is the title of a new series of the SHS Newsletter. In future, you can regularly read about innovations from the world of medical technology that have had a profound influence on our lives. Today’s milestone concerns a tiny balloon that has already saved countless lives. We thank the University Library […]

Coming up with reliable figures for the process of infection with the coronavirus requires tests that are dependable and, above all, quick. With the Octea SARS-CoV-2 system, GNA Biosolutions has developed a molecular, highly sensitive test method that delivers a test result with 96.7 percent accuracy in decentralized laboratories in approximately 40 minutes’ time. Octea […]

For the medium-sized Swiss firm Tri Dental Implants Int. AG, CE approval for matrix®, the world’s first digital dental implant, represents a breakthrough! This is a real milestone for matrix®, which permits realisation of single-tooth treatment or multi-unit bridges directly on the implant, without the use of an abutment. The CE approval means that the […]